CyageniCyagen
HomeAI Assistant
Toolbox
Databases
Resources
About Us
AI Tools
RNA Splicer
ASO Designer
Pathogenicity Predictor
Bioinfo Tools
Sequence Viewer
Mutation Direct
Antibody Discovery
Target Insights
Computational Analysis
Databases
Gene Database
Disease Database
Model Database
Mutation Database
Learn
Learning Center
Explore
iCyagen
Cyagen
OriCellTM
AbSeekTM
Contact
Contact Us
EN
中文
Myeloma, Multiple (MM)
Alias:
Multiple Myeloma
|
Medullary Plasmacytoma
|
Myeloma
|
Plasma Cell Myeloma
|
Kahler Disease
|
Myelomatosis
|
Plasma Cell Dyscrasia
|
Kahler's Disease
|
Mm
|
Multiple Myeloma, Susceptibility to, Somatic Mutation
|
Multiple Myeloma, Resistance to, Somatic Mutation
|
Multiple Myeloma Without Mention of Remission
|
Multiple Myeloma/plasma Cell Myeloma
|
Immunoglobulin Deposition Disease
|
Myeloid Neoplasm of Plasma Cell
|
Myeloma, Plasma Cell, Malignant
|
Monostotic Plasma Cell Myeloma
|
Primary Systemic Amyloidosis
|
Plasma Cell Myeloid Neoplasm
|
Kahler-Bozzolo Disease
|
Plasma Cell Neoplasm
|
Plasma Cell Myelomas
|
Multiple Myeloma Nos
|
Primary Amyloidosis
|
Plasmacytic Myeloma
|
Multiple Myelomata
Basic Information
Medical Symptom
Gene & Mutation
Related Drugs
Disease Model
References Literature
Multiple myeloma is a cancer of plasma cells in the bone marrow, characterized by abnormal cell growth leading to tumors in bones, bone pain, fractures, weakness, and fatigue. Symptoms may include frequent infections, thirst, and urination. Diagnosis involves lab tests and imaging, with treatment options such as chemotherapy, stem cell transplantation, radiation, or targeted therapy. The disorder can cause anemia, weakened immune system, kidney problems, and hypercalcemia. It is more common in older individuals, African Americans, and those with a family history of the condition.
Related ID:
MALACARDS: MYL069
|
OMIM: 254500
|
MESH: D009101
|
ICD11: 526287100
Basic Information
Inheritance
Age of Onset
Prevalence
Related Genes
Related Mouse Models
Reference
MALACARDS
Ot
Other
Adult
1-9/100000
Prevalence at birth:
1-9/100000 (United States)
Annual incidence:
1-9/100000 (Worldwide, France, Europe, United States, Iran, Islamic Republic of, Australia, Denmark)
Point prevalence:
1-5/10000 (Europe)
662
6182
63
MYL069
Medical Symptom
Phenotype Information Associated with the Current Disease:
Categorization: Anatomical classification of the disease manifestations.
HPO Frequency/Orphanet Frequency: Indicates the probability of the manifestation occurring in the current disease, allowing sorting by probability.
HPO Source Accession: Links to HPO for detailed manifestation information.
Data Source: HPO, Orphanet
Gene & Mutation
Genes and Mutations Associated with the Current Disease:
Function: Primary biological roles of the genes.
Score: Indicates the strength of the association between the disease and the gene, with higher scores reflecting stronger associations.
Count: Number of mutations associated with the disease-gene pair. The number in parentheses represents the total data points linked to the same ClinVar ID. Clicking the number reveals mutation details.
Data Source: Clinvar
Related Drugs
Drugs Related to the Current Gene, Displaying CAS Number, Status and Phase.
Data Source: Clinical Trials
Related Mouse Models
Mouse Models Related to the Current Gene. Click on the model name to view detailed information.
Data Source: MGI, Cyagen
References Literature
Most Relevant Literature for the Current Gene, Filterable by Year, Article Type, and Sortable by Impact Factor.
Data Source: UniProt, PubMed
Cyagen
Home
Tools
Database
Resources
About Us
Email: icyagen-support@cyagen.com
Phone: +86 18620792549
Address: No.98, Xiangxue Road, Huangpu District, Guangzhou City
Follow us on social media
Contact us via LinkedIn
Link: https://www.linkedin.com/company/cyagen-biosciences
Copy
Contact us via YouTube
Link: https://www.youtube.com/@Cyagen
Copy
iCyagen
Copyright © 2024 Cyagen Biosciences. All Rights Reserved.
Privacy Policy
User Agreement
Back to top